Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Metabolic pathways on the designer drug of abuse 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice
Publication

Publications

Metabolic pathways on the designer drug of abuse 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice

Title
Metabolic pathways on the designer drug of abuse 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice
Type
Other Publications
Year
2004
Authors
Carmo, H
(Author)
FFUP
View Personal Page Send message Search for Participant Publications View Authenticus page View ORCID page
de Boer, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Remiao, F
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Carvalho, F
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
dos Reys, LA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bastos, ML
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Scientific classification
FOS: Medical and Health sciences > Basic medicine
Other information
Authenticus ID: P-000-9ZC
Language: English
Type (Professor's evaluation): Scientific
Contact: helenacarmo@ff.up.pt
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

4-methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways (2003)
Article in International Scientific Journal
Carmo, H; Remiao, F; Carvalho, F; Fernandes, E; de Boer, D; dos Reys, LA; Bastos, MD
Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration (2004)
Article in International Scientific Journal
Carmo, H; de Boer, D; Remiao, F; Carvalho, F; dos Reys, LA; Bastos, MD
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human (2005)
Article in International Scientific Journal
Carmo, H; Hengstler, JG; de Boer, D; Ringel, M; Remiao, F; Carvalho, F; Fernandes, E; dos Reys, LA; Oesch, F; Bastos, MD
Identification of 4-methylthioamphetamine and some of its metabolites in mouse urine by GC-MS after acute administration (2002)
Article in International Scientific Journal
Carmo, H; de Boer, D; Remiao, F; Carvalho, F; dos Reys, LA; Bastos, MD
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse (2004)
Article in International Scientific Journal
Carmo, H; Hengstler, JG; de Boer, D; Ringel, M; Carvalho, F; Fernandes, E; Remiao, F; dos Reys, LA; Oesch, F; Bastos, MD

Of the same scientific areas

Xanthohumol restores hepatic glucolipid metabolism balance in type 1 diabetic Wistar rats (2017)
Thesis
Mario Rui Ascensão Dias de Lima Fontes
von Willebrand Factor as a Biomarker of Aortic Stenosis Severity (2022)
Thesis
Ana Rita Nunes Albuquerque
Vírus do Papiloma Humano em Universitárias em Maputo. Moçambique: Utilização de um Método de Auto-Colheita (2017)
Thesis
Yara Priscilla Pedro Bule
Utilizadores Frequentes do Serviço de Urgência Pediátrico. Mito ou Realidade? (2018)
Thesis
Carlos Miguel Lopes do Nascimento
Usos da Informática em Dados Administrativos em Gestão e Auditoria de Saúde, revisão de literatura (2017)
Thesis
Ricardo Lourenço dos Santos

See all (1900)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 02:35:34 | Privacy Policy | Personal Data Protection Policy | Whistleblowing